Rising Pharma Holdings Achieves USFDA Approval for Mesalamine Suppositories

Unknown Apr 02, 2026 950 Views

Bliss GVS Pharma has announced a significant milestone as its partner, Rising Pharma Holdings, secures final approval from the United States Food and Drug Administration (USFDA) for Mesalamine Suppositories. This approval marks a crucial step in expanding access to effective treatments for inflam...

Stay Ahead – Explore Now! Fitch Rates IIFL Finance's USD500 Million Notes Final 'B+'